FIELD: medicine.
SUBSTANCE: in blood serum on the first day of treatment level of serum alveomucin is determined. If its value is from 44 un/ml to 52 un/ml, volume of lungs tissue affection is estimated as nidal, if value is over 52 un/ml - as lobe.
EFFECT: application of invention allows with high accuracy estimate volume of lung tissue affection in case of out-of hospital pneumonia.
3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING SEVERITY OF COMMUNITY-ACQUIRED PNEUMONIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE | 2021 |
|
RU2767892C1 |
| METHOD OF TREATING FOCAL AND CAVITARY CHANGES IN LUNGS OF POST-COVID ETIOLOGY | 2023 |
|
RU2809304C1 |
| METHOD OF PREDICTING INCREASE OF VOLUME OF PULMONARY TISSUE INJURY AT INFILTRATIVE TUBERCULOSIS | 2016 |
|
RU2633077C1 |
| METHOD FOR PREDICTING OUTCOMES OF PNEUMONIA IN COVID-19 | 2022 |
|
RU2795095C1 |
| METHOD OF ASSESSING THE PROBABILITY OF THE PRESENCE OF PULMONARY TUBERCULOSIS IN THE GENERAL MEDICAL NETWORK IN PATIENTS WITH A PRELIMINARY DIAGNOSIS OF COMMUNITY-ACQUIRED PNEUMONIA | 2022 |
|
RU2799137C1 |
| METHOD FOR PREDICTING THE SEVERITY OF PNEUMONIA IN COVID-19 | 2022 |
|
RU2795093C1 |
| METHOD FOR PREDICTION OF FATAL OUTCOME IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA | 2011 |
|
RU2472155C1 |
| METHOD OF EARLY DIAGNOSTICS OF VIRAL PNEUMONIA | 2010 |
|
RU2440577C1 |
| METHOD FOR RAPID DIAGNOSIS OF THE SEVERITY OF PNEUMONIA IN COVID-19 | 2022 |
|
RU2789426C1 |
| METHOD OF TREATING PNEUMONIA | 2009 |
|
RU2391105C1 |
